Literature DB >> 21850187

Pediatric cataract, myopic astigmatism, familial exudative vitreoretinopathy and primary open-angle glaucoma co-segregating in a family.

D A Mackey1, A W Hewitt, J B Ruddle, B Vote, R G Buttery, C Toomes, R Metlapally, Y J Li, K N Tran-Viet, F Malecaze, P Calvas, T Rosenberg, J A Guggenheim, T L Young.   

Abstract

PURPOSE: To describe an Australian pedigree of European descent with a variable autosomal dominant phenotype of: pediatric cortical cataract (CC), asymmetric myopia with astigmatism, familial exudative vitreoretinopathy (FEVR), and primary open-angle glaucoma (POAG).
METHODS: Probands with CC, FEVR, and POAG were enrolled in three independent genetic eye studies in Tasmania. Genealogy confirmed these individuals were closely related and subsequent examination revealed 11 other family members with some or all of the associated disorders.
RESULTS: Twelve individuals had CC thought to be of childhood onset, with one child demonstrating progressive lenticular opacification. One individual had severe retinal detachment while five others had dragged retinal vessels. Seven individuals had POAG. Seven individuals had myopia in at least one eye ≤-3 Diopters. DNA testing excluded mutations in myocilin, trabecular meshwork inducible glucocorticoid response (MYOC) and tetraspanin 12 (TSPAN12). Haplotype analysis excluded frizzled family receptor 4 (FZD4) and low density lipoprotein receptor-related protein 5 (LRP5), but only partly excluded EVR3. Multipoint linkage analysis revealed multiple chromosomal single-nucleotide polymorphisms (SNPs) of interest, but no statistically significant focal localization.
CONCLUSIONS: This unusual clustering of ophthalmic diseases suggests a possible single genetic cause for an apparently new cataract syndrome. This family's clinical ocular features may reflect the interplay between retinal disease with lenticular changes and axial length in the development of myopia and glaucoma.

Entities:  

Mesh:

Year:  2011        PMID: 21850187      PMCID: PMC3156798     

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


Introduction

In this study, we describe the novel overlapping phenotype of congenital cataract (CC), familial exudative vitreoretinopathy (FEVR), myopia, and primary open-angle glaucoma (POAG) segregating in an apparently autosomal-dominant fashion. In Australia, myopia affects approximately 15% of the population [1], POAG affects approximately 3% of the population [2], CC occurs in approximately 2.2 out of every 10,000 births [3], and FEVR affects an estimated 7 out of every 1000,000 people (derived from comparing 13 indexed FEVR cases [4] to 420 CC cases [3]). If we were to consider these diseases as completely independent clinical entities, the highly unlikely probability of a patient having all four diseases simultaneously, or of the four diseases co-segregating, would be approximately 1 in 148 billion. This denominator is more than 20 times the total population of earth today. Interestingly, to some extent these clinical entities can be associated with each other. Many investigators have reported the association of high myopia with cataract, glaucoma, and retinal detachment [5]. Other associations are less common: •anterior polar cataracts, seen in aniridia, are often associated with glaucoma [6]; rubella embryopathy is associated with both congenital glaucoma and CC [6]; •aphakic glaucoma is observed very frequently, and cataract can develop as a complication of POAG-filtering surgery [6]; retinal detachment is a feature of Stickler syndrome and is associated often with cortical lens opacities [7]; retinal detachment from retinopathy of prematurity (ROP) is associated with myopia and cataract [8]. Retinal dystrophies are associated with myopia and posterior subcapsular cataracts [9]. Although researchers have identified genes associated with each of these disorders, the genetic mechanisms and their interactions still are not fully understood.

Methods

We identified three closely-related index cases from three genetic-eye-disease studies: VI:7 from the Glaucoma Inheritance Study in Tasmania (GIST) [10], VIII:7 from the Cataract Inheritance Study in South Eastern Australia (CISSEA) [3], and VIII:8 from the Familial Retinal Detachment Study (FRDA) [4]. The GIST study had ethical approval from the Royal Hobart Hospital; the CISSEA and FRDA studies had ethical approval from the Royal Victorian Eye and Ear Hospital. In each case, the work was conducted in accordance with the tenets of the Declaration of Helsinki. When we realized that the index cases were a grandmother and two of her grandchildren who were genetic first cousins, we decided to examine the entire pedigree in detail to characterize a potentially novel phenotype. Our ultimate aim was to identify the gene responsible for this apparently-autosomal-dominant disorder. From the genealogy of the index cases [11] we identified the living members of five lineal generations, as well as surviving more-distant relatives. We invited these family members for a comprehensive ophthalmic examination [12], including: •a LogMAR visual acuity test, •the Goldmann applanation intraocular pressure (IOP) measurement, •refraction using a HARK-598 autorefractor (Carl Zeiss Meditec, Miami, FL), •axial length measurement using an Ocuscan® (Alcon, Inc., Ft Worth, TX), •corneal pachymetry using an IOPac (Heidelberg Instruments, Heidelberg, Germany), •lens photographs, •stereoscopic optic disc photography using a Nidek 3Dx camera (Nidek, Gamagori, Japan), and •examination of the peripheral retina. All participants provided venous blood or saliva specimens for DNA extraction and genetic analysis. Genotyping was performed using fluorescently-tagged microsatellite markers as described previously [13]. Briefly, standard PCR reactions were carried out in a 25 μl volume containing 50 ng of genomic DNA using Invitrogen Taq DNA polymerase and buffers (Invitrogen). Microsatellite markers (including primer details; Table 1) surrounding EVR1 (D11S4187, D11S896, and D11S1367), EVR4 (D11S2006, D11S4095, and D11S937) and EVR3 (D11S929, D11S4115, D11S4154, D11S4203, D11S4083, and D11S4102) were selected from the genome browser. Following amplification, PCR products were resolved using an ABI 3730 DNA sequencer and analyzed using GeneMapper® software from the same manufacturer (Applied Biosystems, Carlsbad, CA). The coding sequence and surrounding exons of myocilin, trabecular meshwork inducible glucocorticoid response (MYOC) and tetraspanin 12 (TSPAN12; primers and conditions are listed in Table 2) were screened using standard direct sequencing protocols as described previously (see above) [14,15].
Table 1

Microsatellite primers and conditions.

MarkerPrimer names and sequences (5’-3’)Size (bp)Annealing temperatureAmplification conditions
D11S4187
F TCTTGAACCCGGGAAG
273-289
55 °C
Invitrogen Taq & buffer
 
R CTGGTGCTGTGCTTGG
 
 
 
D11S896
F ATCTCCCCTAGCTGTTTTGGA
169-183
60 °C
Invitrogen Taq & buffer
 
R AGTTCATATCCACCTCACACA
 
 
 
D11S1367
F GCTGACATTTATTCACATGGC
224-244
60 °C
Invitrogen Taq & buffer
 
R ACAGTGTTATCTCCCTGGCA
 
 
 
D11S2006
F CTTGTGGGCTGTAGTTTGCT
~325
55 °C
Invitrogen Taq & buffer
 
R AAAGAGTAAACTCAATGAAAGATGC
 
 
 
D11S4095
F TCCCTGGCTATCTTGAATC
173-205
55 °C
Invitrogen Taq & buffer
 
R CTTGACTGGGTCCACG
 
 
 
D11S937
F CTAATAAACAAATCCCTCTACCTCC
230-264
60 °C
Invitrogen Taq & buffer
 
R TAGTCAGTCAGGGACCCAAGT
 
 
 
D11S929
F AGGCCCTTCCAAGATCAG
218-240
60 °C
Invitrogen Taq & buffer
 
R CCCAGTTGCCGAACTACC
 
 
 
D11S4115
F TGGCATGTAAATNTAAGAGACTCAC
185-199
50 °C
Invitrogen Taq & buffer
 
R CTGCTACCTCAGAAGTATCTCAA
 
 
 
D11S4154
F ATCCCTTGGCTTTCTCAGAGCAC
146-158
65 °C
Invitrogen Taq & buffer
 
R GGTGCCCCTAACCTCCATGT
 
 
 
D11S4203
F GAATAGCCACTGACTTCAGG
218-278
60 °C
Invitrogen Taq & buffer
 
R CAGGATGCTGGAATAGAGAA
 
 
 
D11S4083
F TTTAACCCAAGGGCAGGAC
178-206
55 °C
Invitrogen Taq & buffer
 
R CATGTGTACCCAAGGGCAG
 
 
 
D11S4102
F CACCACTGGGTACTGCCATC
142-174
60 °C
Invitrogen Taq & buffer
 R GCTAAATCCTGGAAAGCCCTG   
Table 2

TSPAN12 primers and PCR conditions.

ExonPrimer names and sequences (5’-3’)Size (bp)Annealing temperatureAmplification conditions
2
TSPAN12-ex2-F ATGTCCCGTGTTCTCTCTCC
382
60 °C
Invitrogen Taq & buffer
 
TSPAN12-ex2-R CCAGGGGTGGATTTCTTTGT
 
 
 
3
TSPAN12-ex3-F TGGTAATTGGGAAAGATATTATGTAAC
291
60 °C
Invitrogen Taq & buffer
 
TSPAN12-ex3-R CCAAAAGATCAAGGAAGAGCA
 
 
 
4
TSPAN12-ex4-F TGAGGCATCATGATTGAAAGAA
346
60 °C
Invitrogen Taq & buffer
 
TSPAN12-ex4-R GCTATCACTGCTCCCTAATCTTGT
 
 
 
5
TSPAN12-ex5-F GGTCCCCTTTCTTGGAGAAC
947
60 °C
Invitrogen Taq & buffer
 
TSPAN12-ex5-R TGGAAATGTGCTTTAGACACAGA
 
 
 
6
TSPAN12-ex6-F GTACAAAATACCTCTTCATTTATCACA
529
60 °C
Hot shot master mix
 
TSPAN12-ex6-R GAAGAAAAGCAGGCCATGAA
 
 
 
7
TSPAN12-ex7-F TGATGACAGATATAGCTCTGGGT
376
60 °C
Hot shot master mix
 
TSPAN12-ex7-R TTTTAAGGCCTTTTACATTTAGACA
 
 
 
8
TSPAN12-ex8-F GCTTTCCCTGAGAACCACTG
605
60 °C
Hot shot master mix
 TSPAN12-ex8-R CCATCCTCATTTTAAAGCATAGA   
For the genotyping platform, we used Linkage Panel IVb of 6008 genome-wide single-nucleotide polymorphisms (SNPs; Illumina, San Diego, CA), and ran the analysis at the Center for Inherited Disease Research (CIDR) of Johns Hopkins University (Baltimore, MD). The results for the pedigree were analyzed with Fastlink using a 2-point analysis (under a dominant model); multipoint results (both parametric and non-parametric) were analyzed using MERLIN. Merlin (Multipoint Engine for Rapid Likelihood Inference) is a software package that uses sparse inheritance trees for pedigree analysis [16].

Results

Genealogical information was available for nine generations of the participants’ family; the individuals examined for this study came from the five most recent generations. •Figure 1 shows the relevant portions of the full pedigree. A consanguineous loop enriched the pedigree with similar genes (RELPAIR [17] analysis suggested a grandparent-grandchild relationship when they were actually great-grandparent and great-grandchild).
Figure 1

Reduced pedigree showing affected individuals. Square=male, circle=female, Top Right filled=myopia, Bottom Right filled=retinal detachment or dragged disc, Bottom Left filled=cataract, Top Left=primary open-angle glaucoma (POAG), n=examined and normal.

Reduced pedigree showing affected individuals. Square=male, circle=female, Top Right filled=myopia, Bottom Right filled=retinal detachment or dragged disc, Bottom Left filled=cataract, Top Left=primary open-angle glaucoma (POAG), n=examined and normal. •Table 3 displays the participants’ ophthalmic phenotypes with autorefraction sphere and cylinder, Keratometry readings, and axial length.
Table 3

Clinical features of family members examined.




Refractive error (D)
Keratometry (D)
Axial Length (mm)



IDSexAge at initial examination (years)RightLeftRightLeftRightLeftCataractGlaucomaDragged disc or retinal detachment
V:2
F
81
−0.75/-2.0x70
+0.75/-1.5x65
45.3/44.3
43.8/42.9
25.05
23.56
Yes
Yes
None
V:4
F
83
−2/-3.25x45
−3.25/-1.0x95
49.2/53.9*
48.6/46.2
25.44
24.37
Yes
Yes
Dragged disc
VI:7
F
65
+0.25/-3.0x180
−0.25/-3.5x75
45.3/42.25*
45.8/43.0
23.75
23.88
Yes
Yes
Dragged disc
VI:12
F
76
NR
NR
NR
NR
NR
NR
Yes
Yes
None
VI:13
F
86
NR
NR
NR
NR
NR
NR
No
Yes
None
VII:1
M
45
0/-0.25x180
0/-0.25x180
NR
NR
NR
NR
No
No
None
VII:3
F
43
0/-1.5x180
0/-0.25x160
40.0/43.1
43.4/44.3
NR
NR
Yes
No
None
VII:5
M
39
−3.25/-4.0x180
−0.5/-1x175
43.5/45.1
43.5/43.6
24.60
22.63
Yes
Yes
Dragged disc
VII:6
F
33
−0.75
−0.5/-0.75x170
NR
NR
NR
NR
No
No
None
VII:7
M
36
−2.25/-0.5x155
−6.25/-1.5x145
42.1/ 42.3
43.5/43.1
24.62
26.77
Yes
Yes
Dragged disc
VII:8
F
38
NR
NR
NR
NR
NR
NR
No
No
None
VIII:3
F
25
−0.25/-0.5x88
+0.5/-0.25x102
NR
NR
NR
NR
Yes
No
None
VIII:5
M
16
−1.75/-1.25x50
−6.25/-6.75x175
40.0/43.1
43.4/ 44.3
NR
NR
Yes
No
None
VIII:6
M
12
−2.0/-5.0x90
+0.5/-0.5x160
NR
NR
NR
NR
Yes
No
None
VIII:7
M
8
−5.75/-0.5x55
−9.25/-3.5x95
41.0/41.8
40.0/41.0
25.65
NR
Yes
No
Dragged disc
VIII:8
F
17
+0.5/-7.25x165
ND
NR
ND
NR
ND
ND
ND
Total detachment OU
VIII:9
F
15
−0.25/-0.5x135
0/-0.25x55
NR
NR
NR
NR
No
No
None
IX:1M31.50/-0.5x12145.3/44.343.8/42.925.05NRYesNoNone

Abbreviations: F, female; M, male; D, diopters; NR, not recorded; ND, not determinable; OU, both eyes. *measured following cataract surgery

Abbreviations: F, female; M, male; D, diopters; NR, not recorded; ND, not determinable; OU, both eyes. *measured following cataract surgery •Figure 2 and Figure 3A-N show photos of the optic disc, retina, and lens.
Figure 2

Lens, optic disc, and retina photos of individuals. In the figure, A indicates individual V:2; B indicates individual V:4; C indicates individual VI:7; D indicates individual VII:3; E indicates individual VII:5; F indicates individual VII:7; G indicates individual VIII:3; H indicates individual VIII:5; I indicates individual VIII:6; J indicates individual VIII:7; K indicates individual VIII:7 followup lens photo five years after first photos; L indicates individual VIII:8; M indicates individual VIII:9; and N indicates individual IX:1.

Figure 3

24–2 Humphrey Visual Fields of Individuals. A indicates individual V:2; B indicates individual V:4; C indicates individual VI:7; D indicates individual VII:5; and E indicates individual VII:7.

Lens, optic disc, and retina photos of individuals. In the figure, A indicates individual V:2; B indicates individual V:4; C indicates individual VI:7; D indicates individual VII:3; E indicates individual VII:5; F indicates individual VII:7; G indicates individual VIII:3; H indicates individual VIII:5; I indicates individual VIII:6; J indicates individual VIII:7; K indicates individual VIII:7 followup lens photo five years after first photos; L indicates individual VIII:8; M indicates individual VIII:9; and N indicates individual IX:1. 24–2 Humphrey Visual Fields of Individuals. A indicates individual V:2; B indicates individual V:4; C indicates individual VI:7; D indicates individual VII:5; and E indicates individual VII:7. •Figure 4A-E show visual field defects.
Figure 4

Haplotype analysis of FEVR genes. Only a subset of the pedigree is displayed; shaded individuals are those whose phenotype suggests FEVR. EVR2 (Norrin) is excluded by the pedigree structure showing male to male transmission. For each locus examined, the affected individuals do not share the same haplotype, indicating that the causative gene does not reside in this region of the chromosomal. A: EVR1 (FZD4); B: EVR3 11p13-p12; C: EVR4 (LRP5).

Haplotype analysis of FEVR genes. Only a subset of the pedigree is displayed; shaded individuals are those whose phenotype suggests FEVR. EVR2 (Norrin) is excluded by the pedigree structure showing male to male transmission. For each locus examined, the affected individuals do not share the same haplotype, indicating that the causative gene does not reside in this region of the chromosomal. A: EVR1 (FZD4); B: EVR3 11p13-p12; C: EVR4 (LRP5). Excluding the married-in spouses, we examined eight female and six male family members aged 3–86 years who apparently were affected. •Visual acuity ranged from 6/5 to perception of light. •Spherical-equivalent refractive error in Diopters (D) ranged from +0.25 D to −11.0 D, with five individuals having myopia in at least one eye of <-3D. Astigmatism varied from 0 to −7.25 D with the rule or −5 D against the rule. •Axial length varied from 23.75 mm to 26.77 mm. •Keratometry readings in eyes that had not been operated on ranged from 40.0 D to 48.62 D, with the largest corneal astigmatism measuring only 3.12 D. •Maximum recorded IOP ranged from 13 mmHg to 36 mmHg. •Central corneal thickness ranged from 510 μm to 590 μm. •One male (VIII:6) was found to have a distance exotropia of 25 D. •Twelve individuals (6 male and 6 female) had CC, thought to be pediatric in onset. (V:2, V:4,VI:7, VI:12, VII:3, VII:5, VII:3, VII:7, VIII:3, VIII:5, VIII:6, VIII:7, IX:1). The youngest age of documented cataract was 3 years of age (IX:1). •One member (VIII:7) had photographic evidence of cataract progression (Figure 3J,K). In addition, iris atrophy was noted at the 3 and 9 o’clock positions. This atrophy possibly became more notable with age (Figure 3K). •One female individual (VIII:8) had severe spontaneous retinal detachment consistent with FEVR, while five individuals (3 male and 2 female) had dragged retinal vessels (V:4,VI:7, VII:5, VII:7, VIII:7). •Seven individuals (5 female and 2 male) had been diagnosed with POAG (V:2, V:4, VI:7, VI:12, VI:13, VII:5, VII:7). Cataract extraction was performed on VII:7 after the cortical wedge progressed to complete lenticular opacification in the left eye and vision declined from 6/18 to 6/60. Post-operatively, this member’s best-corrected visual acuity improved to 6/6. Refraction in the left eye changed from −6.25/-1.5x145 to +0.00/-0.50 X 98 following cataract surgery. The brother of this individual (VII:5) had similar surgery for cataract and astigmatism, but his visual acuity did not improve from 6/60.

Systemic associations

None of the family members had dysmorphia or an unusual stature consistent with the facial or body habitus features of Stickler syndrome. One member, who had not worn ear protection in his industrial employment, had noise-related hearing loss (VII:7) and one (V:4) had age-related hearing loss. Only one member (V:4) was found to have a single café-au-lait spot. One participant (VII:7) had previously been diagnosed with pulmonary alveolar proteinosis (PAP) and treated with repeated pulmonary lavage. PAP is a rare disorder related to the receptor pathway of the granulocyte macrophage–colony stimulating factor (GM-CSF); it was diagnosed after recurrent bouts of pneumonia in adult life. No other family member has experienced similar medical problems; no individual reported any renal problems. MYOC screening of the index case revealed no mutation [14]. Haplotype analysis of a central portion of the pedigree excluded the EVR1 frizzled family receptor 4 (FZD4) and EVR4 low density lipoprotein receptor-related protein 5 (LRP5) FEVR genes (Figure 4). Unfortunately, the EVR3 locus could be only partially excluded due to uninformative markers. Given that this gene had not been identified, we cannot exclude this locus fully. Direct screening of VIII:8 excluded the recently-identified FEVR gene TSPAN12. The family was included in the International High Myopia Consortium linkage analysis [16]; however, the family was dropped from the multipoint analyses for chromosomes 3, 4, 6, 7, 8, 11, and 12 due to the pedigree’s complexity. Table 4 displays the two-point linkage results for this family showing the highest scoring logarithm of odds (LOD) scores above 1.5. There were multiple chromosomal SNPs of interest, but no statistically significant focal localization.
Table 4

Summary of the Johns Hopkins Center for Inherited Disease Research (CIDR) results for the family.

ChromosomeMarkerPosition (cM)2PT-parametric (Fastlink)MPT-non-parametricMPT-parametric
1
rs1981193
121.82
1.863
NS
NS
1
rs1806753
160.34
1.079
NS
NS
2
rs2053372
47.98
1.592
NS
NS
2
rs2008535
54.9
1.128
NS
NS
2
rs764464
65.31
1.328
NS
NS
2
rs1022298
117.27
1.162
NS
NS
2
rs264963
117.39
1.162
NS
NS
3
rs2076993
46.5
1.166
NS
NS
3
rs1348979
49.44
1.166
NS
NS
3
rs1127732
59.51
1.097
NS
NS
3
rs713144
60.4
1.477
NS
NS
3
rs1382554
60.41
1.097
NS
NS
3
rs1405793
64.61
1.159
NS
NS
3
rs1495704
65.68
1.159
NS
NS
3
rs1995137
66.29
1.159
NS
NS
3
rs1351631
67.73
1.522
NS
NS
3
rs737516
67.73
1.522
NS
NS
3
rs1013758
67.81
1.522
NS
NS
3
rs844438
78.91
1.123
NS
NS
3
rs1447971
82.11
1.842
NS
NS
3
rs935734
92.98
1.586
NS
NS
3
rs1019374
95
1.069
NS
NS
3
rs1388276
99.96
1.116
NS
NS
4
rs751266
67.19
1.054
NS
NS
4
rs896656
93.96
1.326
NS
NS
8
rs2203837
23.58
1.615
NS
NS
8
rs334206
32.33
1.241
NS
NS
8
rs241202
48.58
1.849
NS
NS
8
rs4107736
50.87
1.248
NS
NS
8
rs1481747
53.13
1.103
NS
NS
8
rs1955185
61.16
1.05
NS
NS
8
rs716583
65.56
1.116
NS
NS
8
rs344278
74.88
1.582
NS
NS
8
rs1460239
112.26
1.618
NS
NS
8
rs1433396
122.14
1.119
NS
NS
8
rs766811
138.68
1.16
NS
NS
9
rs1532310
0.124137
1.522
NS
NS
9
rs1532309
0.124434
1.522
NS
NS
9
rs1143025
30.9
1.176
NS
NS
9
rs1029015
35.12
1.767
NS
NS
9
rs716933
60.37
1.089
NS
NS
9
rs987187
60.4
1.128
NS
NS
9
rs1333342
69.96
1.477
NS
NS
10
rs1346300
75.86
1.522
NS
NS
11
rs676943
125.79
1.015
NS
NS
12
rs871880
58.31
1.123
NS
NS
12
rs7134835
161.7
1.2
NS
NS
12
rs1278602
171.56
1.089
NS
NS
12
rs1278601
171.57
1.089
NS
NS
12
rs937538
171.78
1.094
NS
NS
13
rs2985981
49.25
1.004
NS
NS
13
rs2031836
115.73
1.003
NS
NS
15
rs1435735
46.31
1.199
NS
NS
15
rs890153
46.31
1.554
NS
NS
15
rs725463
60.22
1.043
NS
NS
15
rs1445020
71.05
1.049
NS
NS
16
rs1019141
19.98
1.49
NS
NS
16
rs889593
122.83
0.018
0.701998
1.0217
16
rs299956
123.93
0.734
0.943619
1.5971
16
rs2076962
125.29
−0.036
1.127055
1.8771
16
rs3794668
126.97
−0.011
1.126755
1.8763
16
rs1056707
128.94
0.057
1.12803
1.8782
16
rs750740
129.03
0.399
1.128125
1.8783
16
rs463701
130.14
−0.067
1.129806
1.8804
16
rs452176
130.21
0.01
1.129825
1.8804
16
rs1006547
130.48
0.018
1.129924
1.8805
16
rs1800330
130.5
0.891
NS
NS
16
rs870856
130.83
1.781
1.126244
1.8762
16
rs8577
130.86
0.549
1.125715
1.8755
17
rs721429
95.95
1.199
NS
NS
18
rs1972602
45.77
1.123
NS
NS
18
rs1548755
51.57
1.252
NS
NS
18
rs1131709
56.82
1.339
NS
NS
18
rs650680
58.25
1.767
NS
NS
18
rs931078
84.57
1.11
NS
NS
20
rs1535382
14.16
1.046
NS
NS
21
rs1041756
33.98
1.07
NS
NS
21rs283957662.261.324NSNS

2-point analyses with Fastlink under a dominant model; multipoint results, both parametric and non-parametric, using the multipoint engine for rapid likelihood inference (MERLIN). Results in italics highlight suggestive loci, while the results in bold were found to be suggestive under all models tested. Abbreviations: Chr, chromosome; cM, centimorgan; 2PT, two point; MPT, multi-point; NS, not significant.

2-point analyses with Fastlink under a dominant model; multipoint results, both parametric and non-parametric, using the multipoint engine for rapid likelihood inference (MERLIN). Results in italics highlight suggestive loci, while the results in bold were found to be suggestive under all models tested. Abbreviations: Chr, chromosome; cM, centimorgan; 2PT, two point; MPT, multi-point; NS, not significant.

Discussion

This Australian pedigree has a unique constellation of ophthalmic features that do not appear to have been described previously. Although we were unable to identify a similar family reported in the literature, the subtle and relatively common clinical features could be overlooked. Many investigators have reported the association of high myopia with ocular morbidities of early-onset cataract, glaucoma and retinal detachment [5]. Pedigrees with myopia are common, but pedigrees with so many members affected with these early ocular issues along with myopic development are extremely rare; we were not able to identify any in the published literature. Although we cannot discount that the associated ocular features may be secondary in origin, this family raises the possibility that the same gene may be responsible for all forms of the pathology observed in the pedigree. Retinal detachment is an uncommon disorder in young people and is most commonly identified in patients with FEVR. X-linked FEVR and Norrie disease arose from mutations in Norrin (excluded by male-to-male transmission, in this pedigree). Dominant FEVR is due to mutations in FZD4 and LRP5, and has been linked to the EVR3 locus [18]. We excluded these loci through linkage analysis. The recently-described gene TSPAN12 (EVR5) was excluded by sequence analysis. Nonetheless, despite a well characterized FEVR mutation, there still can be considerable variation in the expressivity of the phenotype and incomplete penetrance [15,18,19] (Personal communication; T.L. Edwards, Centre for Eye Research Australia, Melbourne, Australia [article in press]). Since the cataract is the most “easily characterized” phenotype in this family’s pedigree, we compared it with other cataract phenotypes described in the literature. Although CC has been linked to or associated with many cataract loci and many chromosomal deletions, the causative mutation has not been identified for the majority of CC and pediatric cataract cases [6]. The peripheral cortical lamella wedge seen in this family is similar to that observed in Stickler syndrome [7] and also with neurofibromatosis Type 2 (NF2) [20]. Interestingly, one case describes NF2 associated with posterior subcapsular cataract and dragged disc [21]. In a series of 15 other NF2 patients, 12 patients had an epiretinal membrane in the macular or paramacular area and 11 patients had central posterior cortical, subcapsular, or peripheral cortical lens opacities [22]. NF2 arises from mutations in the Merlin gene on chromosome 22q12.2 [23]. The one case of PAP [24] prompted an investigation of possible genes involved in the GM-CSF pathway using the Online Mendelian Inheritance in Man® (OMIM) database at Johns Hopkins University. Of three loci associated with PAP, one gene located at chromosome 22q12.2-q13.1, Granulocyte-macrophage Colony-stimulating factor receptor, beta (CSF2RB) is adjacent to Merlin. Notably, on reviewing myopia loci, the myopia linkage found by Stambolian and colleagues [25] for marker D22S685 lies in chromosome region 22q12. This region has also been replicated in the Beaver Dam Eye study [26]. The refractive error recorded in this pedigree is atypical; most hereditary myopia is symmetric and usually is not associated with high astigmatism. To date there has been little investigation of the genetics of astigmatism, though genetic factors are likely to play a role [27]. It would appear that the myopia in this family originates in increased axial length rather than in the more usual primary lenticular fault. The degree of astigmatism in severely affected members, however, appeared to be both lenticular and corneal, suggesting a common mechanism of growth or compensation. The causative interaction of the cataract and the increased myopia remains to be elucidated, but may involve visual form deprivation [28]. We hope that characterization of this unusual phenotypic constellation will identify other families with similar characteristics. Further characterization of the genes involved in this family using methods such as next-generation sequencing should help shed light on the genetics of the four clinical entities —POAG, CC, FEVR, and myopia— as well as their interactions. In time, this further work also may help clarify the molecular pathways of developing myopia involving retinal signaling, lens growth and axial length.
  27 in total

1.  Genomewide linkage scan for myopia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 22q12.

Authors:  Dwight Stambolian; Grace Ibay; Lauren Reider; Debra Dana; Chris Moy; Melissa Schlifka; Taura Holmes; Elise Ciner; Joan E Bailey-Wilson
Journal:  Am J Hum Genet       Date:  2004-07-23       Impact factor: 11.025

2.  The problem of overlapping glaucoma families in the Glaucoma Inheritance Study in Tasmania (GIST).

Authors:  J Sack; D L Healey; A P de Graaf; R M Wilkinson; C H Wilkinson; J M Barbour; M A Coote; P J McCartney; J L Rait; R L Cooper; M A Ring; D A Mackey
Journal:  Ophthalmic Genet       Date:  1996-12       Impact factor: 1.803

3.  Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; P R Healey
Journal:  Ophthalmology       Date:  1996-10       Impact factor: 12.079

4.  Retinal changes associated with neurofibromatosis 2.

Authors:  S M Meyers; F A Gutman; L D Kaye; A D Rothner
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  The ocular presentation of neurofibromatosis 2.

Authors:  N K Ragge; M E Baser; V M Riccardi; R E Falk
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

6.  Inheritance of astigmatism: evidence for a major autosomal dominant locus.

Authors:  M Clementi; M Angi; P Forabosco; E Di Gianantonio; R Tenconi
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

7.  Glaucoma phenotype in pedigrees with the myocilin Thr377Met mutation.

Authors:  David A Mackey; Danielle L Healey; John H Fingert; Michael A Coote; Tiffany L Wong; Colleen H Wilkinson; Paul J McCartney; Julian L Rait; A Pauline de Graaf; Edwin M Stone; Jamie E Craig
Journal:  Arch Ophthalmol       Date:  2003-08

8.  Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy.

Authors:  Carmel Toomes; Helen M Bottomley; Sheila Scott; David A Mackey; Jamie E Craig; Binoy Appukuttan; J Timothy Stout; Christina J Flaxel; Kang Zhang; Graeme C M Black; Alan Fryer; Louise M Downey; Chris F Inglehearn
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-07       Impact factor: 4.799

9.  Aetiology of congenital and paediatric cataract in an Australian population.

Authors:  M G Wirth; I M Russell-Eggitt; J E Craig; J E Elder; D A Mackey
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

10.  Distinctive cataract in the Stickler syndrome.

Authors:  C M Seery; R C Pruett; R M Liberfarb; B Z Cohen
Journal:  Am J Ophthalmol       Date:  1990-08-15       Impact factor: 5.258

View more
  3 in total

1.  Sonic Hedgehog Intron Variant Associated With an Unusual Pediatric Cortical Cataract.

Authors:  Terri L Young; Kristina N Whisenhunt; Sarah M LaMartina; Alex W Hewitt; David A Mackey; Stuart W Tompson
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

2.  Pathogenic variants and associated phenotypic spectrum of TSPAN12 based on data from a large cohort.

Authors:  Wenmin Sun; Xueshan Xiao; Shiqiang Li; Xiaoyun Jia; Panfeng Wang; Qingjiong Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-27       Impact factor: 3.117

3.  Genome-wide association study for refractive astigmatism reveals genetic co-determination with spherical equivalent refractive error: the CREAM consortium.

Authors:  Qing Li; Robert Wojciechowski; Claire L Simpson; Pirro G Hysi; Virginie J M Verhoeven; Mohammad Kamran Ikram; René Höhn; Veronique Vitart; Alex W Hewitt; Konrad Oexle; Kari-Matti Mäkelä; Stuart MacGregor; Mario Pirastu; Qiao Fan; Ching-Yu Cheng; Beaté St Pourcain; George McMahon; John P Kemp; Kate Northstone; Jugnoo S Rahi; Phillippa M Cumberland; Nicholas G Martin; Paul G Sanfilippo; Yi Lu; Ya Xing Wang; Caroline Hayward; Ozren Polašek; Harry Campbell; Goran Bencic; Alan F Wright; Juho Wedenoja; Tanja Zeller; Arne Schillert; Alireza Mirshahi; Karl Lackner; Shea Ping Yip; Maurice K H Yap; Janina S Ried; Christian Gieger; Federico Murgia; James F Wilson; Brian Fleck; Seyhan Yazar; Johannes R Vingerling; Albert Hofman; André Uitterlinden; Fernando Rivadeneira; Najaf Amin; Lennart Karssen; Ben A Oostra; Xin Zhou; Yik-Ying Teo; E Shyong Tai; Eranga Vithana; Veluchamy Barathi; Yingfeng Zheng; Rosalynn Grace Siantar; Kumari Neelam; Youchan Shin; Janice Lam; Ekaterina Yonova-Doing; Cristina Venturini; S Mohsen Hosseini; Hoi-Suen Wong; Terho Lehtimäki; Mika Kähönen; Olli Raitakari; Nicholas J Timpson; David M Evans; Chiea-Chuen Khor; Tin Aung; Terri L Young; Paul Mitchell; Barbara Klein; Cornelia M van Duijn; Thomas Meitinger; Jost B Jonas; Paul N Baird; David A Mackey; Tien Yin Wong; Seang-Mei Saw; Olavi Pärssinen; Dwight Stambolian; Christopher J Hammond; Caroline C W Klaver; Cathy Williams; Andrew D Paterson; Joan E Bailey-Wilson; Jeremy A Guggenheim
Journal:  Hum Genet       Date:  2014-11-04       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.